Indian companies are the main supplier of generic drugs to the world and procure almost 70% of the active pharmaceutical ingredients (APIs) for their medicines from China. The coronavirus outbreak has disrupted international businesses dependent on Chinese supplies and industry experts expect Indian generic drugmakers to face supply shortages from China if epidemic drags on.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/39jYhy0
via IFTTT
0 comments:
Post a Comment